Jazz Pharmaceuticals plc Profit Margin

Jazz Pharmaceuticals plc (JAZZ) currently reports a profit margin of 20.45% as of June 2026. That compares with -9.91% in the prior-year period — up 306.4% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Jazz Pharmaceuticals plc's profit margin history and peer comparisons.

Jazz Pharmaceuticals plc's profit margin increased from -9.91% to 20.45% — a 306.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jazz Pharmaceuticals plc's profit margin of 20.45% is lower than the Healthcare sector average of 21.34%. That is roughly 4.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Jazz Pharmaceuticals plc's current 20.45% should be judged against Healthcare norms (sector average: 21.34%) and against JAZZ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 20.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Jazz Pharmaceuticals plc, and consider following JAZZ for alerts when major investors trade the stock.